Angiodynamics (ANGO) Other Non-Current Liabilities (2012 - 2026)

Angiodynamics' Other Non-Current Liabilities history runs 15 years deep, the most recent figure standing at $16.3 million for Q2 2026.

• Quarterly Other Non-Current Liabilities fell 3.54% year-over-year to $16.3 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $16.3 million (down 3.54% YoY) and the FY2026 annual result came in at $16.3 million, down 3.54% from the prior year.
• Other Non-Current Liabilities was $16.3 million for Q2 2026 at Angiodynamics, down from $16.7 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $17.4 million in Q1 2025 and bottomed at $2.6 million in Q4 2023.
• A 5-year average of $11.5 million and a median of $14.2 million in 2025 frame the typical range for Other Non-Current Liabilities.
• Annual changes were most pronounced in 2023 — Other Non-Current Liabilities plunged 81.58% — and 2024, when it jumped 355.53%.
• Angiodynamics' Other Non-Current Liabilities stood at $9.1 million in 2022, then slumped by 71.32% to $2.6 million in 2023, then soared by 355.53% to $11.9 million in 2024, then jumped by 43.88% to $17.1 million in 2025, then dropped by 4.39% to $16.3 million in 2026.
• Business Quant data shows ANGO's Other Non-Current Liabilities at $16.3 million in Q2 2026, $16.7 million in Q1 2026, and $17.1 million in Q4 2025.